Role of Oral Valganciclovir in Sick Preterm with Cytomegalovirus Virus Infection and Ventilation Dependence

Anumodan Gupta; Aditi Saini; Anukul Gowda; Sandeep Kadam

doi:10.4103/ijrc.ijrc_28_18

SEARCH WITHIN CONTENT

Online First

Role of Oral Valganciclovir in Sick Preterm with Cytomegalovirus Virus Infection and Ventilation Dependence

Anumodan Gupta, Aditi Saini, Anukul Gowda, Sandeep Kadam

Keywords : Cytomegalovirus, persistent pulmonary hypertension, preterm, valganciclovir

Citation Information : Gupta A, Saini A, Gowda A, Kadam S. Role of Oral Valganciclovir in Sick Preterm with Cytomegalovirus Virus Infection and Ventilation Dependence. Indian J Respir Care 2019; 8 (2):116-117.

DOI: 10.4103/ijrc.ijrc_28_18

License: CC BY-NC-SA 4.0

Published Online: 05-12-2022

ARTICLE
REFERENCES

Abstract

Cytomegalovirus (CMV) is the most common congenital viral infection in neonates. Postnatal infection regarding infants rarely has significant clinical consequences. However, preterm may be at higher risk of developing symptomatic postnatal CMV disease. A multipara woman delivered vaginally a male preterm infant at 30 weeks' gestation who was suspected of early.onset sepsis in view of chronic leaking. The baby developed severe hypoxemia, and persistent pulmonary hypertension after delivery, with progressive deterioration and minimal effect of advanced ventilation, antibiotics, and pulmonary vasodilators. Sepsis screen and cultures for bacteria and fungi were negative. The baby was having enlarged liver and spleen which was noticed on day 15 of life. TORCH titer of the baby revealed CMV IgM and subsequently, CMV was isolated in the urine and in the blood plasma by polymerase chain reaction. Oral valganciclovir improved hematological parameters of the baby and respiratory support could be weaned. CMV being the most common intrauterine infection should be considered in differential diagnosis in unusual presentation of suspected sepsis and oral valganciclovir can be considered as good option for treatment.

HTML PDF Share

Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality. Pediatr Infect Dis J 1992;11:93-9.
Demmler GJ. Congenital cytomegalovirus infection treatment. Pediatr Infect Dis J 2003;22:1005-6.
Mussi-Pinhata MM, Pinto PC, Yamamoto AY, Berencsi K, de Souza CB, Andrea M, et al. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates. J Med Virol 2003;69:232-9.
Bello C, Whittle H. Cytomegalovirus infection in Gambian mothers and their babies. J Clin Pathol 1991;44:366-9.
Zhang XW, Li F, Yu XW, Shi XW, Shi J, Zhang JP. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: A longitudinal cohort study in Qinba mountain area, China. J Clin Virol 2007;40:180-5.
Marin LJ, Santos de Carvalho Cardoso E, Bispo Sousa SM, Debortoli de Carvalho L, Marques Filho MF, Raiol MR, et al. Prevalence and clinical aspects of CMV congenital infection in a low-income population. Virol J 2016;13:148.
Stagno S, Pass RF, Dworsky ME, Alford CA. Congenital and perinatal cytomegalovirus infections. Semin Perinatol 1983;7:31-42.
Mussi-Pinhata MM, Yamamoto AY, Moura Brito RM, de Lima Isaac M, de Carvalho e Oliveira PF, Boppana S, et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 2009;49:522-8.
Revello MG, Lilleri D, Zavattoni M, Furione M, Middeldorp J, Gerna G, et al. Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay. J Clin Microbiol 2003;41:1772-4.

PDF Share